Neoadjuvant Darovasertib in Primary Uveal Melanoma
for Uveal Melanoma
35 locations incl. Scottsdale
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07015190·Phase 3·Recruiting·Listed Jun 2025
Clinical research site in Cleveland, Ohio · Cleveland Clinic-Cole Eye Institute, 9500 Euclid Ave # S40, Cleveland, OH 44195 · (216) 444-2020 · Website
Part of Cleveland Clinic
As of July 2026, 10 paid clinical trials are recruiting at Cleveland Clinic, Cole Eye Institute in Cleveland, Ohio. Active studies at this site cover conditions such as Uveal Melanoma, Choroidal Melanoma and Indeterminate Lesions. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Cleveland, OH · Ohio clinical trials